Edition:
United States

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

5.21USD
8 Dec 2017
Change (% chg)

$0.64 (+14.00%)
Prev Close
$4.57
Open
$4.62
Day's High
$5.25
Day's Low
$4.60
Volume
616,928
Avg. Vol
355,378
52-wk High
$9.25
52-wk Low
$3.95

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Robert Ingram

74 2017 Chairman of the Board

Jon Stonehouse

56 2007 President, Chief Executive Officer, Director

Thomas Staab

52 2013 Chief Financial Officer, Senior Vice President, Principal Accounting Officer, Treasurer

Yarlagadda Babu

64 2013 Senior Vice President - Drug Discovery

Lynne Powell

50 2015 Senior Vice President, Chief Commercial Officer